Skip to main content

Table 1 U251 secretome after treatment with pre-miR-93 or antagomiR-93

From: Regulation of IL-8 gene expression in gliomas by microRNA miR-93

Protein

Release (pg/ml)

Fold release after pre-miR-93 treatment

Fold release after antagomiR-93 treatment

miR-93 dependency (miR-93INDEX)a

PDGF-bb

5.96

0.40

1.76

0.23

IL-1ra

475.02

0.49

0.80

0.61

IL-2

3.84

1.32

0.62

2.10

IL-6

85.8

0.39

1.28

0.30

IL-7

4.17

0.38

1.64

0.23

IL-8

838.38

0.27

1.63

0.17

IL-9

3.53

0.59

1.47

0.40

IL-10

25.15

0.48

1.57

0.30

IL-12

105.99

0.46

1.59

0.29

IL-15

9.60

0.72

0.40

1.80

IL-17

14.80

0.50

1.09

0.47

FGF

49.55

0.52

1.33

0.39

G-CSF

6.30

0.53

1.37

0.39

GM-CSF

114.50

0.49

1.44

0.34

IFN-γ

14.47

0.36

1.32

0.27

IP-10

7.80

0.45

1.37

0.33

MCP-1(MCAF)

4743.32

0.38

1.51

0.25

MIP-1β

2.35

0.59

1.27

0.47

RANTES

13.69

0.68

1.32

0.51

TNF-α

8.51

0.43

1.32

0.33

VEGF

9469.12

0.49

1.56

0.31

  1. amiR-93 dependency: fold (pre-miR-93 treatment)/fold (antagomiR-93 treatment)